Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Pi Network's token fell 12% over the last seven days, slipping below $0.13. Analysts see oversold conditions and upco...
Ethereum briefly stalls as a major corporate ETH buy tests the market. BitMine Immersion Technologies added a large c...
A growing trend among wealthy couples over 60 uses a roth conversion strategy affluent to convert a $1.4 million trad...
Tesla commands a market cap near $1.5 trillion, fueling questions about whether tesla worth more than the rest of the...
A 73-year-old retiree with $1.6 million in a traditional 401(K) confronts a sizable first required minimum distributi...
SpaceX is poised to redefine the IPO window, with investors racing to price in a future where Elon Musk's company goe...
A monthly dividend growth fund has outperformed SCHD by 38 percentage points over the past decade, challenging the tr...
A new investor suit alleges Zillow misled investors about its February 2025 Redfin rental listings deal, intensifying...
Despite a chorus of buy ratings on Shopify, a dissenting view flags limited upside as AI tools and monetization effor...
Elon Musk’s net worth surged above $1.1 trillion, driven by SpaceX and Tesla gains, rewriting the hierarchy at the ve...
A top tech stock faces a likely pullback in the second half of 2026 as demand shifts and costs rise. Traders should h...